Filing Details
- Accession Number:
- 0001209191-15-036806
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-28 20:37:27
- Reporting Period:
- 2015-04-24
- Filing Date:
- 2015-04-28
- Accepted Time:
- 2015-04-28 20:37:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1411158 | Anacor Pharmaceuticals Inc. | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202769 | L Paul Berns | C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-03-20 | 5,000 | $0.00 | 303,760 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2015-04-24 | 7,833 | $64.69 | 295,927 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-24 | 16,267 | $65.51 | 279,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-24 | 900 | $66.31 | 278,760 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-27 | 7,624 | $59.79 | 271,136 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-27 | 2,078 | $60.46 | 269,058 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-27 | 2,100 | $61.74 | 266,958 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-27 | 3,448 | $62.68 | 263,510 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-27 | 9,750 | $63.85 | 253,760 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Reflects a bona fide charitable gift of shares donated by the reporting person.
- This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person for tax and estate planning purposes.
- The price reported in Column 4 is a weighted average price.
- These shares were sold in multiple transactions at prices ranging from $64.00 to $64.94, inclusive.
- These shares were sold in multiple transactions at prices ranging from $65.04 to $65.99, inclusive.
- These shares were sold in multiple transactions at prices ranging from $66.11 to $66.47, inclusive.
- These shares were sold in multiple transactions at prices ranging from $59.16 to $60.10, inclusive.
- These shares were sold in multiple transactions at prices ranging from $60.16 to $61.06, inclusive.
- These shares were sold in multiple transactions at prices ranging from $61.20 to $62.10, inclusive.
- These shares were sold in multiple transactions at prices ranging from $62.38 to $63.30, inclusive.
- These shares were sold in multiple transactions at prices ranging from $63.50 to $64.41, inclusive.
Billionaire Hedge Funds
